Zhang Sisi, Ding Rongjing, Chen Sikun, Meng Xiaoping, Jianchao Li, Wang Dao Wen, Hu Dayi
Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Rehabilitation, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Front Cardiovasc Med. 2023 Jun 19;10:1210068. doi: 10.3389/fcvm.2023.1210068. eCollection 2023.
The study aimed to evaluate the current status of cardiac rehabilitation programs in China by registering and tracking patients undergoing CR programs in the database. Data were extracted from the online registry platform of the China Society of Cardiopulmonary Prevention and Rehabilitation from February 2012 to December 2021. Overall, data on 19,896 patients with cardiovascular diseases (CVDs) from 159 hospitals in 34 provinces of China were extracted. From a time point of view, the number of patients who had undergone CR and institutions that perform CR showed the first decline in 2009 and then increased until 2021. From a geographic point of view, the degree of participation varied greatly among regions, most of which were concentrated in eastern parts of China. A higher population of patients who underwent CR were male, aged less than 60 years, with low-a risk for coronary heart disease (CHD), and tended to choose the hospital-based CR program among all cases registered in the database. The top three diseases in the patients who participated in CR were CHD, hypertension, and metabolic syndrome (MS). Centers with CR were more likely to be tertiary-level hospitals. After adjusting for baseline values, there were significant differences in post-CR exercise capacity among the three groups (home-based CR group, hospital-based CR group, and hybrid CR group), which were in favor of the hybrid CR group compared with other groups. The underutilization of CR is a global issue, not just in China. Despite the number of CR programs showing an increasing trend in the past years, CR in China is still in the preliminary stage of development. Furthermore, the participation of CR in China shows wide diversity across geography, disease, age, sex, risk stratification, and hospital-level factors. These findings reinforce the importance of the implementation of effective measures to improve the participation, enrollment in, and uptake of cardiac rehabilitation.
该研究旨在通过在数据库中登记和跟踪接受心脏康复(CR)项目的患者,评估中国心脏康复项目的现状。数据取自中国心肺预防与康复学会2012年2月至2021年12月的在线注册平台。总体而言,提取了来自中国34个省份159家医院的19896例心血管疾病(CVD)患者的数据。从时间角度来看,接受CR的患者数量和开展CR的机构数量在2009年首次下降,之后持续增加直至2021年。从地理角度来看,各地区的参与程度差异很大,其中大部分集中在中国东部地区。接受CR的患者中男性居多,年龄小于60岁,冠心病(CHD)低风险,且在数据库中登记的所有病例中倾向于选择基于医院的CR项目。参与CR的患者中排名前三的疾病是CHD、高血压和代谢综合征(MS)。开展CR的中心更有可能是三级医院。在调整基线值后,三组(家庭式CR组、医院式CR组和混合式CR组)在CR后的运动能力方面存在显著差异,与其他组相比,混合式CR组更具优势。CR利用不足是一个全球性问题,并非仅在中国存在。尽管CR项目数量在过去几年呈上升趋势,但中国的CR仍处于发展初期。此外,中国CR的参与情况在地理、疾病、年龄、性别、风险分层和医院级别因素方面存在广泛差异。这些发现强化了实施有效措施以提高心脏康复参与度、登记率和接受率的重要性。